IBOV 176,723.62 ▼ 0.46% IPSA 10,916.70 ▼ 0.84% IPC MEX 66,247.47 ▼ 1.56% MERVAL 3,319,522 ▼ 1.78% COLCAP 2,283.28 ▼ 0.60% BVL PERÚ 57,575.02 — — USD/BRL5.08▼ 0.08% USD/MXN17.51▼ 0.07% USD/CLP945.00▲ 1.00% USD/COP3,200▼ 0.47% USD/PEN3.40▲ 0.09% USD/ARS1,488▼ 0.05% USD/UYU40.14▲ 1.38% USD/PYG6,025▲ 1.32% USD/BOB11.03▲ 3.10% USD/DOP57.95▼ 0.34% USD/CRC451.03▲ 2.19% USD/GTQ7.62▲ 2.30% USD/HNL26.74▲ 0.80% USD/NIO36.62▲ 0.26% USD/VES740.37▲ 0.46% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 0.37% USD/TTD6.73▲ 1.17% EUR/BRL5.78▲ 0.07% BRENT 100.36 ▼ 0.33% WTI 91.66 ▼ 0.57% IRON ORE 161.91 — — COPPER 6.32 ▲ 0.29% GOLD 4,032 ▼ 0.36% SILVER 57.68 ▼ 0.21% SOY 1,248 ▲ 0.87% CORN 488.75 ▲ 5.33% WHEAT 701.75 ▲ 0.79% COFFEE 310.75 ▼ 1.86% SUGAR 14.68 ▼ 0.41% ORANGE JUICE 145.50 ▼ 3.19% COTTON 81.53 ▲ 2.08% COCOA 5,367 ▲ 0.73% BEEF 221.48 ▼ 0.77% CATTLE 340.13 ▼ 0.31% LITHIUM 69.02 ▲ 0.03% PETR4 42.95 ▲ 0.87% VALE3 75.68 ▲ 0.77% ITUB4 42.56 ▼ 0.79% BBDC4 18.72 ▼ 1.32% ABEV3 15.92 ▼ 1.30% BBAS3 20.93 ▼ 0.76% B3SA3 15.65 ▼ 1.57% WEGE3 45.67 ▼ 2.29% PRIO3 60.54 ▲ 1.29% SUZB3 42.43 ▼ 0.54% RENT3 37.14 — 0.00% AZZA3 17.05 ▼ 4.27% CSAN3 3.90 ▼ 0.51% RAIZ4 0.27 — 0.00% PCAR3 2.87 ▲ 4.36% GMAT3 3.87 ▼ 1.02% PSSA3 55.18 ▼ 0.49% CVCB3 1.31 ▲ 3.15% POSI3 3.67 ▼ 0.81% SLCE3 13.77 ▼ 1.36% NATU3 8.56 ▼ 1.38% BRKM5 6.17 ▲ 1.65% RANI3 7.93 ▼ 0.88% CSNA3 5.30 ▼ 1.49% CMIN3 5.83 ▼ 0.17% USIM5 8.49 ▼ 1.85% GGBR4 24.06 — 0.00% ENEV3 25.70 ▼ 1.04% CPFE3 46.22 ▼ 1.05% CMIG4 11.19 ▼ 0.18% EQTL3 39.02 ▼ 0.84% LREN3 13.37 ▼ 1.26% VIVT3 34.70 ▼ 1.92% RAIL3 13.96 ▲ 2.35% KLABIN 17.66 ▼ 1.51% RAIA DROGASIL 18.19 ▼ 0.55% RDOR3 33.67 ▼ 2.38% HAPV3 10.47 ▼ 8.08% FLRY3 16.58 ▼ 0.42% SMTO3 15.71 ▼ 2.12% UGPA3 33.39 ▲ 1.71% VBBR3 35.60 ▲ 1.77% BBSE3 42.40 ▼ 0.42% BPAC11 56.30 ▼ 1.26% CURY3 29.62 ▼ 1.92% AERI3 2.02 ▼ 1.46% VIVARA 21.45 ▼ 0.46% COMPASS 25.08 ▲ 1.09% VAMOS 3.21 ▼ 0.62% SANB11 26.63 ▼ 1.19% ASAI3 8.02 ▼ 4.52% SBSP3 29.00 ▼ 0.99% WALMEX 47.27 ▼ 2.84% GMEXICO 208.35 ▼ 3.10% FEMSA 222.31 ▼ 2.38% CEMEX 21.48 ▼ 3.11% GFNORTE 189.00 ▼ 1.37% BIMBO 59.00 ▼ 2.16% TELEVISA 9.79 ▼ 0.31% AMX 22.84 ▲ 0.66% GAP 375.37 ▼ 0.36% ASUR 269.84 ▼ 1.35% OMA 227.18 ▼ 0.66% KOF 179.71 ▼ 1.56% GRUMA 268.11 ▼ 4.40% KIMBER 39.20 ▲ 0.98% SQM-B 65,499 ▲ 0.68% COPEC 6,260 ▼ 4.43% BSANTANDER 80.00 ▲ 0.19% FALABELLA 6,058 ▲ 0.26% ENELAM 85.00 ▲ 0.56% CENCOSUD 1,968 ▼ 2.08% CMPC 1,051 ▼ 1.78% BANCO CHILE 190.72 ▼ 1.44% LATAM AIR 23.50 ▼ 2.45% YPF 82,475 ▼ 0.03% GGAL 7,945 ▼ 3.99% PAMPA 5,630 ▲ 0.09% TXAR 679.00 ▲ 1.65% ALUAR 982.50 ▲ 0.87% TGS 9,995 ▲ 0.91% CEPU 2,420 ▲ 0.37% MIRGOR 16,725 ▼ 1.18% COME 42.53 ▼ 1.41% LOMA NEGRA 3,778 ▼ 0.85% BYMA 292.50 ▼ 1.02% TELECOM ARG 4,325 ▼ 2.15% ECOPETROL 16.33 ▼ 2.16% BANCOLOMBIA 86.79 ▲ 2.52% GRUPO AVAL 4.93 ▼ 2.18% CREDICORP 387.63 ▼ 1.53% SOUTHERN COPPER 182.22 ▼ 6.78% BUENAVENTURA 31.32 ▼ 2.40% MERCADOLIBRE 1,799 ▼ 0.03% NUBANK 14.19 ▼ 2.21% XP 16.83 ▼ 2.72% PAGSEGURO 9.46 ▼ 2.17% STONE 10.98 ▼ 3.35% GLOBANT 30.61 ▼ 0.20% TECNOGLASS 43.75 ▼ 3.26% GAP AIRPORT 215.45 ▼ 0.96% ASUR 269.84 ▼ 1.35% OMA AIRPORT 104.14 ▼ 1.15% AMX ADR 25.95 ▼ 0.65% FEMSA ADR 127.08 ▼ 2.93% CEMEX ADR 12.26 ▼ 3.62% PETROBRAS ADR 19.00 ▲ 0.58% VALE ADR 14.83 ▼ 0.13% ITAU ADR 8.35 ▼ 1.53% SANTANDER BR 5.36 ▼ 1.74% AMBEV ADR 3.09 ▼ 1.47% CSN 1.06 ▼ 2.75% GERDAU 4.77 — 0.00% LATAM ADR 49.79 ▼ 2.87% BTC 65,286 ▲ 0.37% ETH 1,876 ▼ 0.08% SOL 75.66 ▼ 0.26% XRP 1.11 ▲ 0.04% BNB 567.87 ▲ 0.16% ADA 0.17 ▼ 0.73% DOGE 0.07 ▼ 0.08% AVAX 6.28 ▲ 0.29% LINK 8.43 ▼ 0.37% DOT 0.81 ▼ 0.29% LTC 46.72 ▼ 0.44% BCH 211.11 ▼ 0.46% TRX 0.33 ▲ 0.28% XLM 0.18 ▲ 0.68% HBAR 0.07 ▼ 0.20% NEAR 1.89 ▲ 0.66% ATOM 1.43 ▲ 0.56% AAVE 95.34 ▲ 0.32% SELIC 14.25% EMBRAER 83.40 ▼ 0.47% EMBRAER ADR 65.47 ▼ 0.88% JBS 12.13 ▼ 0.98% JBS BDR 61.82 ▲ 0.03% MBRF3 15.59 ▼ 2.74% MBRFY 3.09 ▼ 3.13% INTER 5.46 ▼ 4.04% IBOV 176,723.62 ▼ 0.46% IPSA 10,916.70 ▼ 0.84% IPC MEX 66,247.47 ▼ 1.56% MERVAL 3,319,522 ▼ 1.78% COLCAP 2,283.28 ▼ 0.60% BVL PERÚ 57,575.02 — — USD/BRL 5.08 ▼ 0.08% USD/MXN 17.51 ▼ 0.07% USD/CLP 945.00 ▲ 1.00% USD/COP 3,200 ▼ 0.47% USD/PEN 3.40 ▲ 0.09% USD/ARS 1,488 ▼ 0.05% USD/UYU 40.14 ▲ 1.38% USD/PYG 6,025 ▲ 1.32% USD/BOB 11.03 ▲ 3.10% USD/DOP 57.95 ▼ 0.34% USD/CRC 451.03 ▲ 2.19% USD/GTQ 7.62 ▲ 2.30% USD/HNL 26.74 ▲ 0.80% USD/NIO 36.62 ▲ 0.26% USD/VES 740.37 ▲ 0.46% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 0.37% USD/TTD 6.73 ▲ 1.17% EUR/BRL 5.78 ▲ 0.07% BRENT 100.36 ▼ 0.33% WTI 91.66 ▼ 0.57% IRON ORE 161.91 — — COPPER 6.32 ▲ 0.29% GOLD 4,032 ▼ 0.36% SILVER 57.68 ▼ 0.21% SOY 1,248 ▲ 0.87% CORN 488.75 ▲ 5.33% WHEAT 701.75 ▲ 0.79% COFFEE 310.75 ▼ 1.86% SUGAR 14.68 ▼ 0.41% ORANGE JUICE 145.50 ▼ 3.19% COTTON 81.53 ▲ 2.08% COCOA 5,367 ▲ 0.73% BEEF 221.48 ▼ 0.77% CATTLE 340.13 ▼ 0.31% LITHIUM 69.02 ▲ 0.03% PETR4 42.95 ▲ 0.87% VALE3 75.68 ▲ 0.77% ITUB4 42.56 ▼ 0.79% BBDC4 18.72 ▼ 1.32% ABEV3 15.92 ▼ 1.30% BBAS3 20.93 ▼ 0.76% B3SA3 15.65 ▼ 1.57% WEGE3 45.67 ▼ 2.29% PRIO3 60.54 ▲ 1.29% SUZB3 42.43 ▼ 0.54% RENT3 37.14 — 0.00% AZZA3 17.05 ▼ 4.27% CSAN3 3.90 ▼ 0.51% RAIZ4 0.27 — 0.00% PCAR3 2.87 ▲ 4.36% GMAT3 3.87 ▼ 1.02% PSSA3 55.18 ▼ 0.49% CVCB3 1.31 ▲ 3.15% POSI3 3.67 ▼ 0.81% SLCE3 13.77 ▼ 1.36% NATU3 8.56 ▼ 1.38% BRKM5 6.17 ▲ 1.65% RANI3 7.93 ▼ 0.88% CSNA3 5.30 ▼ 1.49% CMIN3 5.83 ▼ 0.17% USIM5 8.49 ▼ 1.85% GGBR4 24.06 — 0.00% ENEV3 25.70 ▼ 1.04% CPFE3 46.22 ▼ 1.05% CMIG4 11.19 ▼ 0.18% EQTL3 39.02 ▼ 0.84% LREN3 13.37 ▼ 1.26% VIVT3 34.70 ▼ 1.92% RAIL3 13.96 ▲ 2.35% KLABIN 17.66 ▼ 1.51% RAIA DROGASIL 18.19 ▼ 0.55% RDOR3 33.67 ▼ 2.38% HAPV3 10.47 ▼ 8.08% FLRY3 16.58 ▼ 0.42% SMTO3 15.71 ▼ 2.12% UGPA3 33.39 ▲ 1.71% VBBR3 35.60 ▲ 1.77% BBSE3 42.40 ▼ 0.42% BPAC11 56.30 ▼ 1.26% CURY3 29.62 ▼ 1.92% AERI3 2.02 ▼ 1.46% VIVARA 21.45 ▼ 0.46% COMPASS 25.08 ▲ 1.09% VAMOS 3.21 ▼ 0.62% SANB11 26.63 ▼ 1.19% ASAI3 8.02 ▼ 4.52% SBSP3 29.00 ▼ 0.99% WALMEX 47.27 ▼ 2.84% GMEXICO 208.35 ▼ 3.10% FEMSA 222.31 ▼ 2.38% CEMEX 21.48 ▼ 3.11% GFNORTE 189.00 ▼ 1.37% BIMBO 59.00 ▼ 2.16% TELEVISA 9.79 ▼ 0.31% AMX 22.84 ▲ 0.66% GAP 375.37 ▼ 0.36% ASUR 269.84 ▼ 1.35% OMA 227.18 ▼ 0.66% KOF 179.71 ▼ 1.56% GRUMA 268.11 ▼ 4.40% KIMBER 39.20 ▲ 0.98% SQM-B 65,499 ▲ 0.68% COPEC 6,260 ▼ 4.43% BSANTANDER 80.00 ▲ 0.19% FALABELLA 6,058 ▲ 0.26% ENELAM 85.00 ▲ 0.56% CENCOSUD 1,968 ▼ 2.08% CMPC 1,051 ▼ 1.78% BANCO CHILE 190.72 ▼ 1.44% LATAM AIR 23.50 ▼ 2.45% YPF 82,475 ▼ 0.03% GGAL 7,945 ▼ 3.99% PAMPA 5,630 ▲ 0.09% TXAR 679.00 ▲ 1.65% ALUAR 982.50 ▲ 0.87% TGS 9,995 ▲ 0.91% CEPU 2,420 ▲ 0.37% MIRGOR 16,725 ▼ 1.18% COME 42.53 ▼ 1.41% LOMA NEGRA 3,778 ▼ 0.85% BYMA 292.50 ▼ 1.02% TELECOM ARG 4,325 ▼ 2.15% ECOPETROL 16.33 ▼ 2.16% BANCOLOMBIA 86.79 ▲ 2.52% GRUPO AVAL 4.93 ▼ 2.18% CREDICORP 387.63 ▼ 1.53% SOUTHERN COPPER 182.22 ▼ 6.78% BUENAVENTURA 31.32 ▼ 2.40% MERCADOLIBRE 1,799 ▼ 0.03% NUBANK 14.19 ▼ 2.21% XP 16.83 ▼ 2.72% PAGSEGURO 9.46 ▼ 2.17% STONE 10.98 ▼ 3.35% GLOBANT 30.61 ▼ 0.20% TECNOGLASS 43.75 ▼ 3.26% GAP AIRPORT 215.45 ▼ 0.96% ASUR 269.84 ▼ 1.35% OMA AIRPORT 104.14 ▼ 1.15% AMX ADR 25.95 ▼ 0.65% FEMSA ADR 127.08 ▼ 2.93% CEMEX ADR 12.26 ▼ 3.62% PETROBRAS ADR 19.00 ▲ 0.58% VALE ADR 14.83 ▼ 0.13% ITAU ADR 8.35 ▼ 1.53% SANTANDER BR 5.36 ▼ 1.74% AMBEV ADR 3.09 ▼ 1.47% CSN 1.06 ▼ 2.75% GERDAU 4.77 — 0.00% LATAM ADR 49.79 ▼ 2.87% BTC 65,286 ▲ 0.37% ETH 1,876 ▼ 0.08% SOL 75.66 ▼ 0.26% XRP 1.11 ▲ 0.04% BNB 567.87 ▲ 0.16% ADA 0.17 ▼ 0.73% DOGE 0.07 ▼ 0.08% AVAX 6.28 ▲ 0.29% LINK 8.43 ▼ 0.37% DOT 0.81 ▼ 0.29% LTC 46.72 ▼ 0.44% BCH 211.11 ▼ 0.46% TRX 0.33 ▲ 0.28% XLM 0.18 ▲ 0.68% HBAR 0.07 ▼ 0.20% NEAR 1.89 ▲ 0.66% ATOM 1.43 ▲ 0.56% AAVE 95.34 ▲ 0.32% SELIC 14.25% EMBRAER 83.40 ▼ 0.47% EMBRAER ADR 65.47 ▼ 0.88% JBS 12.13 ▼ 0.98% JBS BDR 61.82 ▲ 0.03% MBRF3 15.59 ▼ 2.74% MBRFY 3.09 ▼ 3.13% INTER 5.46 ▼ 4.04%
since 2009
Friday, July 24, 2026

Covid-19 Brazil

Bolsonaro calls Covid vaccine being developed by São Paulo´s Butantan Institute “mandrake”

By · April 23, 2021 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Brazilian President Jair Bolsonaro attacked the São Paulo-based world-renowned Butantan Institute when inviting the Minister of Science and Technology, Marcos Pontes, to talk about a vaccine entirely produced in the country by researchers from Ribeirão Preto.

President Jair Bolsonaro called the new vaccine against Covid-19 developed by the Butantan Institute “mandrake”. The entity, which is linked to the government of São Paulo and has already developed Coronavac in partnership with the Chinese laboratory Sinovac, is now working to create a Brazilian immunizer, called Butanvac.

Mandrake. (Photo internet reproduction)
The mythical mandrake. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Bolsonaro attacked the institute when he invited the Minister of Science and Technology, Marcos Pontes, to talk about a vaccine produced entirely in the country by researchers from the State University of São Paulo in Ribeirão Preto (USP-RP). “This is 100% Brazilian, isn’t it? This is not that ‘mandrake’ vaccine from São Paulo, no? This one is 100% Brazilian. How is it? What is its name?”, provoked the president, on Thursday, 22, during a live broadcast to social networks.

The studies are being conducted at the University of São Paulo School of Medicine in Ribeirão Preto, in partnership with two private companies – Farmacore Biotechnology Ltda. in Brazil and PDS Biotechnology Corporation in the U.S. According to Marcos Pontes, the forecast is to make the new vaccine available by the end of the year.

Read: Butantan announces first home-grown Brazilian vaccine and will start testing it in humans

The announcement of the request to the National Health Regulatory Agency (Anvisa) for phase 1 and 2 tests of this immunizer was made in March. At the time, Pontes announced the initiative only hours after Butantan had announced that it is studying a totally national vaccine, the Butanvac.

Butantan is also responsible for developing the Coronavac, in partnership with the manufacturer Sinovac, from China. According to data from the government, this vaccine is the main immunization available to Brazilians today, representing more than 80% of the doses already applied.

Read: New “all Brazilian” Covid-19 vaccine is not Brazilian after all

The Butanvac technology, presented by the Butantan Institute as being 100% national, was developed last year by researchers from the Mount Sinai Institute in New York. On a later note, Butantan acknowledged that it “signed a partnership and has the license to use and explore part of the technology, which was developed by the Icahn School of Medicine of Mount Sinai Hospital in New York obtain the virus.”

President again criticizes lockdown

In Thursday’s April 22 broadcast, the president again criticized harsh social isolation measures recommended by health officials to contain the spread of the new coronavirus. “It’s been a year, and they keep doing lockdown as if it’s medicine to stop the virus. It’s actually impoverishing our population more and more,” he said.

In talking about Covid-19, the president once again defended the use of a drug with no proven efficacy against the disease. “Why can’t you talk about medicine, God in heaven? Last year I talked about medicine, and I was massacred. I took a drug last year (hydroxychloroquine). If I have a problem again, I will take it. It’s okay,” he affirmed.

Mandrake is the root of a plant, historically derived either from plants of the genus Mandragora found in the Mediterranean region or from other species, such as Bryonia alba, the English mandrake, which have similar properties.

Because mandrakes contain deliriant hallucinogenic tropane alkaloids and the shape of their roots often resembles human figures, they have been associated with a variety of superstitious practices throughout history. They have long been used in magic rituals, today also in contemporary pagan traditions such as Wicca and Odinism.

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.